You are viewing: China Custom Antibody Market analysis
Part of: Custom Antibody Market (Global)

The China Custom Antibody Market was valued at $26.9 Million in 2024 and projected to reach to $45.2 Million by 2029, representing a compound annual growth rate of 10.9%. China's custom antibody market is poised for sustained growth through 2029, supported by accelerating biopharmaceutical R&D activities and increased government funding for life sciences innovation.

China Custom Antibody Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Custom Antibody Market Trends and Insights

  • This growth trajectory reflects China's strengthening position in biopharmaceutical research and development, driven by increased investment in therapeutic antibody development and rising demand from domestic pharmaceutical companies.
  • China's expanding biotech ecosystem and government support for life sciences innovation are accelerating adoption of custom antibody solutions across research institutions and commercial entities. The 10.9% compound annual growth rate (CAGR) in China significantly outpaces global trends, underscoring the country's strategic importance in the custom antibody sector.
  • China's growing capabilities in monoclonal antibody manufacturing and immunotherapy research are attracting both domestic and international collaborations.
  • By 2029, China is expected to consolidate its role as a critical hub for custom antibody development, supported by cost-competitive manufacturing and expanding clinical trial infrastructure..

Key Market Statistics

  • CAGR (2024-2029) 10.9% CAGR
  • Market Size, 2024 ~USD 26.9 Million
  • Forecast, 2029 ~USD 45.2 Million
  • Country China

China Custom Antibody Market Overview

Rapid Market Expansion :

China's custom antibody market is growing at 10.9% CAGR, outpacing the global rate of 9.2%, driven by increased R&D investments and domestic pharmaceutical innovation.

Strong Valuation Growth :

Market size is projected to expand from USD 26.9 million in 2024 to USD 45.2 million by 2029, representing a 68% increase over five years.

Biopharmaceutical Sector Momentum :

China's strengthening position in therapeutic antibody development is fueled by government support, rising biotech investments, and growing demand from domestic pharmaceutical companies.

Strategic Research Hub Development :

Expansion of research capabilities and manufacturing infrastructure positions China as a key player in custom antibody production for both domestic and international markets.

China Custom Antibody Market Dynamics

  • The country's expanding ecosystem of biotech companies and contract research organizations is driving demand for specialized antibody solutions.
  • Domestic pharmaceutical firms are increasingly investing in therapeutic antibody development, creating significant opportunities for custom antibody manufacturers and service providers. The market outlook remains positive as China strengthens its position in the global biopharmaceutical supply chain.
  • Rising healthcare expenditures, coupled with initiatives to develop innovative treatments, will continue to propel market expansion.
  • Strategic partnerships between Chinese biotech firms and international pharmaceutical companies are expected to further accelerate adoption of custom antibody technologies and services..

Market Ecosystem

logo-mobile

CUSTOM ANTIBODY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides custom antibody development and production services, including monoclonal, polyclonal, and recombinant antibody generation. Its services cover antigen design, antibody screening, purification, and characterization for research and diagnostic applications. Supports the development of application-specific antibodies with defined target specificity and performance, helping pharmaceutical companies, biotechnology firms, and academic researchers accelerate target validation and assay development.
company logo
Offers custom antibody production and engineering services through its antibody development capabilities, including GeneArt high-throughput antibody expression, gene synthesis, cloning, transient expression, purification, and quality control. Enables researchers to obtain custom antibodies for research and development workflows, supporting faster antibody production, consistent quality, and applications in biologics development, protein analysis, and diagnostic research.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • China's custom antibody market is valued at USD 26.9 million in 2024 and will grow to USD 45.2 million by 2029, representing a 10.9% CAGR.
    • China's growth rate significantly exceeds global averages, positioning the country as a high-growth market within the Asia Pacific region.
    • Government support for biotechnology and rising R&D investments are driving custom antibody adoption across China's pharmaceutical and research sectors.
    • China's cost-competitive manufacturing and expanding clinical infrastructure position it as an attractive hub for custom antibody development and production.

    Custom Antibody Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment ONCOLOGY (Indication)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.2% from 2024 to 2029
    Largest Segment RESEARCH (Application)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.9 (2029)
    Segments Covered Service, Type, Source, Application, Indication, End User

    China Custom Antibody Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Service

    • Antibody Development
    • Antibody Fragmentation & Labeling
    • Antibody Fragmentation & Labelling
    • Antibody Production & Purification

    By Type

    • Antibody Characterization
    • Antigen Preparation
    • Immunization & Hybridoma Production
    • Monoclonal Antibodies
    • Other Antibodies
    • Other Custom Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies

    By Source

    • Mice
    • Other Sources
    • Rabbits

    By Application

    • Research
    • Therapeutic

    By Indication

    • Cardiovascular Diseases
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Other Indications

    By End User

    • Academic & Research Institutes
    • Contract Research Organizations
    • Cros
    • Pharmaceutical & Biotechnology Companies

    CHINA: CUSTOM ANTIBODY MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES13.614.215.416.918.620.622.925.510.6
    CONTRACT RESEARCH ORGANIZATIONS333.23.53.84.14.54.98.7
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES25.22729.432.435.839.844.349.611
    TOTAL41.844.148.152.758.264.571.78010.7

    Target Audience

    • Biopharmaceutical Companies : Chinese and international pharma firms need market intelligence to assess custom antibody sourcing opportunities, competitive positioning, and R&D investment priorities within China's expanding biotech ecosystem.
    • Contract Research Organizations (CROs) : CROs operating in or targeting China require detailed market data to evaluate service demand, pricing strategies, capacity planning, and growth opportunities in therapeutic antibody development.
    • Antibody Manufacturing Providers : Custom antibody manufacturers need China-specific insights to identify market entry points, understand local competition, assess customer demand, and develop localized business strategies.
    • Investment & Venture Capital Firms : Investors evaluating biotech opportunities in China require comprehensive market analysis to identify promising startups, assess market growth potential, and make informed funding decisions.
    • Healthcare & Life Sciences Consultants : Consultants advising clients on China market expansion need detailed market segmentation, growth forecasts, and competitive landscape data to develop effective market entry and growth strategies.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation metrics for China's custom antibody market with verified 2024 baseline (USD 26.9M) and 2029 forecast (USD 45.2M), enabling accurate business planning and investment decisions.
    • Competitive Intelligence : Understand China-specific market dynamics, local player positioning, and growth drivers that differentiate this market from global trends, supporting strategic market entry and expansion strategies.
    • Investment & Funding Insights : Identify high-growth opportunities within China's biopharmaceutical sector, including emerging therapeutic antibody segments and contract research demand from domestic pharmaceutical companies.
    • Regulatory & Market Landscape : Gain insights into China's unique regulatory environment, government support initiatives, and infrastructure development that impact custom antibody market accessibility and growth potential.
    • Strategic Partnership Opportunities : Leverage detailed China market analysis to identify collaboration prospects with local biotech firms, research institutions, and pharmaceutical companies driving custom antibody adoption.

    Frequently asked questions

    What is the current size of China's custom antibody market?

    China's custom antibody market was valued at USD 26.9 million in 2024 and is expected to grow to USD 45.2 million by 2029.

    What is the projected growth rate for China's custom antibody market?

    China's custom antibody market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.

    What factors are driving growth in China's custom antibody market?

    Key drivers include government support for biotechnology, increased R&D investments, rising demand from domestic pharmaceutical companies, and China's expanding capabilities in monoclonal antibody manufacturing and immunotherapy research.

    How does China's custom antibody market growth compare to global trends?

    China's 10.9% CAGR significantly outpaces the global market CAGR of 9.2%, reflecting China's strategic importance and accelerating adoption of custom antibody solutions.

    What role does China play in the global custom antibody market?

    China is emerging as a critical hub for custom antibody development and manufacturing, supported by cost-competitive production, expanding clinical trial infrastructure, and increasing international collaborations.

    RESEARCH METHODOLOGY

    The global custom antibody market is projected to reach USD 1.13 billion by 2031, up from USD 0.72 billion in 2026, reflecting a 9.5% CAGR over the forecast period. Market estimation involved four major activities to estimate the current size of the custom antibody market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. Following this, data triangulation was used to estimate the market size of segments and subsegments.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the custom antibody market. The secondary sources used for this study include Antibody Society, Antibody Therapeutics, Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), American Medical Association (AMA), Association of Medical Laboratory Immunologists (AMLI), Central Drugs Standard Control Organisation (CDSCO), Center for Drug Evaluation and Research (CDER), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), World Health Organization (WHO), and United States Food & Drug Administration (USFDA).

    Secondary sources also include corporate and regulatory filings (annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess market prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Breakup of Primary Profiles:

    Custom Antibody Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The global size of the custom antibody market was estimated using multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following.

    Custom Antibody Market: Top-Down and Bottom-Up Approach

    Custom Antibody Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, the total market was divided into several segments and subsegments. To finish the overall market analysis and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used where applicable. The data were triangulated by examining various factors and trends from both the demand and supply sides.

    Market Definition

    Custom antibody services include the production of antibodies from a wide variety of host species, depending on the desired outcome of the research study. These services range from antigen preparation, immunization, hybridoma production, and antibody characterization to production, purification, and labeling. The report includes the market size and forecast for custom antibody development, production, purification, and labeling services.

    Key Stakeholders

    • Academic & Research Institutes
    • Custom Antibody Service Vendors
    • Contract Research Organizations (CROs)
    • Medical Device Companies
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Private Research Firms

    Report Objectives

    • To define, describe, and forecast the custom antibody market based on service, type, source, application, indication, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall custom antibody market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East (GCC Countries), and Africa
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as service launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the provided market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific custom antibody market into countries
    • A further breakdown of the Rest of Europe custom antibody market into countries
    • A further breakdown of the Rest of Latin America custom antibody market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Segment Analysis

    • Cross-segment analysis.

     

    Get the Full Custom Antibody Market Report

    Full forecast, segment splits, and company analysis for all Custom Antibody Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status